title: The host battles drug-resistant tuberculosis.
authors.affiliation: Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. CAST, Karolinska University Hospital, Stockholm, Sweden. markus.maeurer@ki.se.
authors.forename: Markus
authors.initials: M
authors.lastname: Maeurer
authors.affiliation: Division of Infection and Immunity, University College London, and NIHR Biomedical research centre, University College London Hospitals NHS Trust, London, UK.
authors.forename: Alimuddin
authors.initials: A
authors.lastname: Zumla
mesh_terms: D054884:Host-Pathogen Interactions; D006801:Humans; D008687:Metformin / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000276:immunology
chemical_list: D008687:Metformin